Modus Therapeutics Holding AB (publ) (MODTX.ST)

SEK 1.89

(-5.04%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue - - - - - -
Gross Profit - - - - - -
Operating Expenses 16.4 Million 18 Million 20.69 Million 6.02 Million 43.57 Million 49.09 Million
Selling, General and Administrative Expenses 7.83 Million 6.98 Million 7.09 Million 2.29 Million 6.84 Million 7.43 Million
Research and Development Expenses 8.48 Million 10.89 Million 13.54 Million 3.72 Million 36.05 Million 41.65 Million
Other Expenses 88 Thousand 120 Thousand 52 Thousand -2000.00 680 Thousand -
Cost and Expenses 16.4 Million 18 Million 20.69 Million 6.02 Million 43.57 Million 49.09 Million
Operating Income -16.4 Million -18 Million -20.69 Million -6.02 Million -43.57 Million -49.09 Million
Interest Expense 1.49 Million 314 Thousand 1000.00 1000.00 1000.00 -
Income Tax Expense - -18 Thousand 1000.00 -1000.00 1000.00 -49.65 Million
Earnings before Tax -17.89 Million -18.32 Million -20.69 Million -6.01 Million -43.57 Million -49.65 Million
Net Income -17.89 Million -18.32 Million -20.69 Million -6.01 Million -43.57 Million -49.65 Million
Earnings Per Share Basic -1.01 -1.14 -1.67 -0.37 -2.71 -3.08
Earnings Per Share Diluted -1.01 -1.14 -1.67 -0.37 -2.71 -3.08
Weighted Average Shares Outstanding 17.74 Million 16.1 Million 12.37 Million 16.1 Million 16.1 Million 16.1 Million
Weighted Average Shares Outstanding (Diluted) 17.74 Million 16.1 Million 12.37 Million 16.1 Million 16.1 Million 16.1 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA 2000.00 -18 Million -20.69 Million -6.01 Million -43.57 Million -
Earnings Before Tax Margin - - - - - -

Income Statement Charts